Abnormal uterine bleeding
Conditions
Interventions
Remimazolam + alfentanil group (RA group):Remimazolam + alfentanil
Remimazolam + remifentanil group (RR group):Remimazolam + remifentanil
Sponsors
Mengcheng County No.1 People's Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. The subjects voluntarily participated and signed the informed consent; 2. They were 18-65 years old; 3. ASA grade is I-II; 4. Body mass index (BMI) 19-30kg / m2; 5. Patients scheduled for hysteroscopy.
Exclusion criteria
Exclusion criteria: 1. History of alcohol abuse or general anesthesia drug allergy; 2. Emergency patients or patients with acute inflammation; 3. Patients with impaired liver or kidney function; 4. Dementia or severe cognitive impairment; 5. Anyone with communication difficulties. 6. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MOAA/S score;Sedative dosage;Dosage of analgesics;Incidence of adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| The changes of systolic blood pressure, diastolic blood pressure, heart rate, moaA / s score and SpO2 were observed and recorded before anesthesia (T0), 2 minutes after anesthesia (T1), at the time of cervical dilatation (T2), at the end of operation (T3) and at the time of recovery (T4).; | — |
Countries
China
Contacts
Public ContactXiaoqiang Zhang
Mengcheng County No.1 People's Hospital
Outcome results
None listed